Similar articles

• Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH).

  Lopes LF, de Camargo B. Lopes LF, et al. Med Pediatr Oncol. 1999 Apr;32(4):315. doi: 10.1002/(sici)1096-911x(199904)32:4<315::aid-mpo17>3.0.co;2-6. Med Pediatr Oncol. 1999. PMID: 10102032 No abstract available.
• Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

  Kitazawa J, Ito E, Arai K, Yokoyama M, Fukayama M, Imashuku S. Kitazawa J, et al. Med Pediatr Oncol. 2001 Aug;37(2):153-4. doi: 10.1002/mpo.1189. Med Pediatr Oncol. 2001. PMID: 11496359 No abstract available.
• Etoposide in Langerhans cell histiocytosis in children: a preliminary experience.

  Basade MM, Nair CN, Kurkure PA, Pai SK, Advani SH. Basade MM, et al. Pediatr Hematol Oncol. 1996 Mar-Apr;13(2):159-62. doi: 10.3109/08880019609030806. Pediatr Hematol Oncol. 1996. PMID: 8721030
• Etoposide in Langerhans cell histiocytosis.

  Gadner H. Gadner H. Pediatr Hematol Oncol. 1996 Jul-Aug;13(4):309-11. doi: 10.3109/08880019609030835. Pediatr Hematol Oncol. 1996. PMID: 8837135 Review. No abstract available.
• Langerhans cell histiocytosis.

  Chu T. Chu T. Australas J Dermatol. 2001 Nov;42(4):237-42. doi: 10.1046/j.1440-0960.2001.00527.x. Australas J Dermatol. 2001. PMID: 11903153 Review.